Leap Therapeutics
LPTX
LPTX
43 hedge funds and large institutions have $4.09M invested in Leap Therapeutics in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% less capital invested
Capital invested by funds: $5.09M → $4.09M (-$1M)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Holders
43
Holding in Top 10
1
Calls
$11K
Puts
$11K
Top Buyers
| 1 | +$311K | |
| 2 | +$22.2K | |
| 3 | +$17.8K | |
| 4 |
Two Sigma Advisers
New York
|
+$12.3K |
| 5 |
VF
Virtu Financial
New York
|
+$12K |
Top Sellers
| 1 | -$745K | |
| 2 | -$216K | |
| 3 | -$123K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$71.6K |
| 5 |
SAM
Simplify Asset Management
Las Vegas,
Nevada
|
-$27.8K |
